Insulet Corp.
PODD
Classificação em ações
#2085
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Preço da ação
$142.84
Última sincronização: 2026-10-20
Valor de mercado
$9.91B
Variação (1 dia)
0.62%
Variação (1 ano)
-56.58%
País
US
Negociar Insulet Corp. (PODD)
Categoria
Healthcare
Receita da Insulet Corp. (PODD)
Receita em Jun 2026 TTM: $3.05B
De acordo com os últimos relatórios financeiros da Insulet Corp., a receita atual da empresa (TTM) é $3.05B. Em 2023, a empresa obteve uma receita de $1.70B um aumento em relação a a receita do ano 2022, que foi de $1.31B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Insulet Corp. de 2002 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $3.05B | 47.40% |
| 2024 | $2.07B | 22.07% |
| 2023 | $1.70B | 30.02% |
| 2022 | $1.31B | 18.79% |
| 2021 | $1.10B | 21.49% |
| 2020 | $904.40M | 22.51% |
| 2019 | $738.20M | 30.93% |
| 2018 | $563.82M | 21.57% |
| 2017 | $463.77M | 26.37% |
| 2016 | $366.99M | 39.07% |
| 2015 | $263.89M | -8.60% |
| 2014 | $288.72M | 16.85% |
| 2013 | $247.08M | 16.90% |
| 2012 | $211.37M | 38.83% |
| 2011 | $152.26M | 57.02% |
| 2010 | $96.97M | 46.85% |
| 2009 | $66.03M | 83.12% |
| 2008 | $36.06M | 169.66% |
| 2007 | $13.37M | 265.06% |
| 2006 | $3.66M | 7,226.00% |
| 2005 | $50.00K | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $46.59B | 1,425.63% |
US
|
|
| $35.48B | 1,062.08% |
IE
|
|
| $25.84B | 746.14% |
US
|
|
| $21.00B | 587.60% |
US
|
|
| - | - |
DE
|
